{"protocolSection": {"identificationModule": {"nctId": "NCT01705964", "orgStudyIdInfo": {"id": "Caperell-Epi-001"}, "organization": {"fullName": "University of Louisville", "class": "OTHER"}, "briefTitle": "Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation", "officialTitle": "Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation"}, "statusModule": {"statusVerifiedDate": "2021-06", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2013-06"}, "primaryCompletionDateStruct": {"date": "2018-04-30", "type": "ACTUAL"}, "completionDateStruct": {"date": "2018-04-30", "type": "ACTUAL"}, "studyFirstSubmitDate": "2012-10-09", "studyFirstSubmitQcDate": "2012-10-11", "studyFirstPostDateStruct": {"date": "2012-10-12", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2020-05-06", "resultsFirstSubmitQcDate": "2021-06-12", "resultsFirstPostDateStruct": {"date": "2021-07-06", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-06-12", "lastUpdatePostDateStruct": {"date": "2021-07-06", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Kerry Caperell", "investigatorTitle": "Assistant Professor of Pediatrics", "investigatorAffiliation": "University of Louisville"}, "leadSponsor": {"name": "University of Louisville", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Project Aim: To determine if intramuscular epinephrine is an effective adjunct to inhaled bronchodilators (\u03b22 agonists) for children with severe asthma exacerbation.\n\nHypothesis: IM epinephrine is an efficacious adjunct to inhaled bronchodilators (\u03b22 agonists) for children with severe asthma exacerbation.\n\nIntervention: Subjects will be randomly assigned (50% chance) to receive a weight based dose of IM epinephrine 1:1000 or no adjunctive medication. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.\n\nIn addition to the study intervention, the standardized treatment pathway based on the current asthma guidelines in use at the investigator's center will be utilized. This pathway includes nebulized albuterol, ipratropium bromide, and systemic corticosteroids. The duration and dosages of these other interventions will be administered at the discretion of the treating provider."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Status asthmaticus", "Asthma exacerbation", "Epinephrine", "Adjunctive therapy"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "SINGLE", "whoMasked": ["OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 49, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "IM epinephrine 1:1000", "type": "EXPERIMENTAL", "description": "IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.", "interventionNames": ["Drug: IM epinephrine 1:1000"]}, {"label": "No intervention", "type": "SHAM_COMPARATOR", "description": "A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.", "interventionNames": ["Other: No intervention"]}], "interventions": [{"type": "DRUG", "name": "IM epinephrine 1:1000", "description": "IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.", "armGroupLabels": ["IM epinephrine 1:1000"]}, {"type": "OTHER", "name": "No intervention", "description": "A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.", "armGroupLabels": ["No intervention"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change in Percent of Predicted Peak Expiratory Flow Rate (PEFR) at t15", "description": "Change in percent of predicted Peak Expiratory Flow Rate (PEFR) 15 minutes after the study intervention (t15).", "timeFrame": "15 minutes after the study intervention"}], "secondaryOutcomes": [{"measure": "Disposition", "description": "Disposition from the ED or rates of discharge.", "timeFrame": "At the time a dispostion from the ED is completed (usually within 4 hours of the study intervention)"}, {"measure": "Change in Percent of Predicted PEFR at t120", "description": "Change in percent of predicted Peak Expiratory Flow Rate (PEFR) 120 minutes after study intervention compared to baseline", "timeFrame": "120 minutes after the study intervention"}, {"measure": "Breaths Per Minute at t120", "description": "breaths per minute at t120 minutes compared to baseline", "timeFrame": "breaths per minute 120 minutes after the study intervention"}, {"measure": "Heart Rate at t120", "description": "Heart rate at t120 minutes in beats per minute (BPM)", "timeFrame": "up to 120 minutes after the study intervention"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Age greater than 6 years and less than 18 years\n2. Pre-existing diagnosis of asthma\n3. Presenting to the ED with an asthma exacerbation\n\nExclusion Criteria:\n\n1. History of chronic lung or upper airway disease other than asthma\n2. History significant, uncorrected congenital heart disease or cardiac arrhythmia\n3. History of thyroid disease\n4. Impending respiratory failure\n5. Allergy to epinephrine\n6. Pregnancy\n7. PEFR\\>60% of predicted and clinical asthma score less than 8", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "6 Years", "maximumAge": "17 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Kerry Caperell, MD", "affiliation": "University of Louisville", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Kosair Children's Hospital", "city": "Louisville", "state": "Kentucky", "zip": "40202", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "IM Epinephrine 1:1000", "description": "IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.\n\nIM epinephrine 1:1000: IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle."}, {"id": "FG001", "title": "No Intervention", "description": "A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.\n\nNo intervention: A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "25"}, {"groupId": "FG001", "numSubjects": "24"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "25"}, {"groupId": "FG001", "numSubjects": "24"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "IM Epinephrine 1:1000", "description": "IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.\n\nIM epinephrine 1:1000: IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle."}, {"id": "BG001", "title": "No Intervention", "description": "A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.\n\nNo intervention: A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "25"}, {"groupId": "BG001", "value": "24"}, {"groupId": "BG002", "value": "49"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "25"}, {"groupId": "BG001", "value": "24"}, {"groupId": "BG002", "value": "49"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "10.00", "spread": "3.42"}, {"groupId": "BG001", "value": "10.58", "spread": "2.76"}, {"groupId": "BG002", "value": "10.29", "spread": "3.10"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "22"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "27"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "17"}, {"groupId": "BG002", "value": "34"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "11"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "4"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "25"}, {"groupId": "BG001", "value": "24"}, {"groupId": "BG002", "value": "49"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change in Percent of Predicted Peak Expiratory Flow Rate (PEFR) at t15", "description": "Change in percent of predicted Peak Expiratory Flow Rate (PEFR) 15 minutes after the study intervention (t15).", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of predicted", "timeFrame": "15 minutes after the study intervention", "groups": [{"id": "OG000", "title": "IM Epinephrine 1:1000", "description": "IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.\n\nIM epinephrine 1:1000: IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle."}, {"id": "OG001", "title": "No Intervention", "description": "A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.\n\nNo intervention: A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "59.56", "spread": "17.11"}, {"groupId": "OG001", "value": "52.45", "spread": "13.73"}]}]}]}, {"type": "SECONDARY", "title": "Disposition", "description": "Disposition from the ED or rates of discharge.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At the time a dispostion from the ED is completed (usually within 4 hours of the study intervention)", "groups": [{"id": "OG000", "title": "IM Epinephrine 1:1000", "description": "IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.\n\nIM epinephrine 1:1000: IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle."}, {"id": "OG001", "title": "No Intervention", "description": "A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.\n\nNo intervention: A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "12"}]}]}]}, {"type": "SECONDARY", "title": "Change in Percent of Predicted PEFR at t120", "description": "Change in percent of predicted Peak Expiratory Flow Rate (PEFR) 120 minutes after study intervention compared to baseline", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of PEFR", "timeFrame": "120 minutes after the study intervention", "groups": [{"id": "OG000", "title": "IM Epinephrine 1:1000", "description": "IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.\n\nIM epinephrine 1:1000: IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle."}, {"id": "OG001", "title": "No Intervention", "description": "A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.\n\nNo intervention: A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "64.51", "spread": "21.68"}, {"groupId": "OG001", "value": "56.18", "spread": "13.36"}]}]}]}, {"type": "SECONDARY", "title": "Breaths Per Minute at t120", "description": "breaths per minute at t120 minutes compared to baseline", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "breaths per minute", "timeFrame": "breaths per minute 120 minutes after the study intervention", "groups": [{"id": "OG000", "title": "IM Epinephrine 1:1000", "description": "IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.\n\nIM epinephrine 1:1000: IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle."}, {"id": "OG001", "title": "No Intervention", "description": "A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.\n\nNo intervention: A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "24.29", "spread": "5.99"}, {"groupId": "OG001", "value": "29.29", "spread": "7.96"}]}]}]}, {"type": "SECONDARY", "title": "Heart Rate at t120", "description": "Heart rate at t120 minutes in beats per minute (BPM)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Beats per minute", "timeFrame": "up to 120 minutes after the study intervention", "groups": [{"id": "OG000", "title": "IM Epinephrine 1:1000", "description": "IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.\n\nIM epinephrine 1:1000: IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle."}, {"id": "OG001", "title": "No Intervention", "description": "A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.\n\nNo intervention: A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "147.65", "spread": "13.91"}, {"groupId": "OG001", "value": "142.29", "spread": "16.30"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "1", "timeFrame": "4 years 10 months", "eventGroups": [{"id": "EG000", "title": "IM Epinephrine 1:1000", "description": "IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.\n\nIM epinephrine 1:1000: IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.", "deathsNumAffected": 0, "deathsNumAtRisk": 25, "seriousNumAffected": 0, "seriousNumAtRisk": 25, "otherNumAffected": 0, "otherNumAtRisk": 25}, {"id": "EG001", "title": "No Intervention", "description": "A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.\n\nNo intervention: A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.", "deathsNumAffected": 0, "deathsNumAtRisk": 24, "seriousNumAffected": 0, "seriousNumAtRisk": 24, "otherNumAffected": 0, "otherNumAtRisk": 24}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Kerry Caperell", "organization": "University of Louisville", "email": "k0cape01@louisville.edu", "phone": "502-629-7212"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2012-10-16", "uploadDate": "2019-09-26T08:24", "filename": "Prot_SAP_000.pdf", "size": 217095}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M16017", "name": "Status Asthmaticus", "relevance": "LOW"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000004837", "term": "Epinephrine"}], "ancestors": [{"id": "D000000316", "term": "Adrenergic alpha-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000009184", "term": "Mydriatics"}, {"id": "D000013566", "term": "Sympathomimetics"}, {"id": "D000014662", "term": "Vasoconstrictor Agents"}], "browseLeaves": [{"id": "M7992", "name": "Epinephrine", "asFound": "Intra-", "relevance": "HIGH"}, {"id": "M30371", "name": "Racepinephrine", "relevance": "LOW"}, {"id": "M211043", "name": "Epinephryl borate", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3668", "name": "Adrenergic alpha-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M12139", "name": "Mydriatics", "relevance": "LOW"}, {"id": "M16345", "name": "Sympathomimetics", "relevance": "LOW"}, {"id": "M17409", "name": "Vasoconstrictor Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "VaCoAg", "name": "Vasoconstrictor Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}